How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
Immunocore (NASDAQ:IMCR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Immunocore (NASDAQ:IMCR) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "strong-buy" rating.